Community/Retail

Examining the clinical applications, effectiveness, safety, and regulation of herbal supplements with a focus on the role of pharmacists.

Pharmacies can strategically invest in AI technologies to streamline operations and improve patient care while addressing cost challenges and maximizing return on investment in 2025.

Fiber-rich foods show improvements in health and reductions in chronic diseases, including obesity, by promoting weight management and enhancing the metabolism.

However, the effects on patient-reported outcomes were inconclusive when compared with self-monitoring blood glucose or the usual care.

The inaccurate claim that these products pose a heavy metal risk is potentially detrimental, as it could discourage pregnant women from using vital prenatal supplements.

Pharmacy students can provide education, patient advocacy, and medication access.

New medications like glucagon-like peptide-1 agonists and resmetirom show promise in reversing fatty liver disease and preventing progression.

Adherence to thiopurine medications after 6 months of use was 87.9% under direct pharmacist care but 65.7% under general practitioner guidance.

Investigators did not report serious adverse events or deaths related to depemokimab in either of the 2 phase 3a clinical trials.

Immunocompromised older adults developed fewer antibodies against RSV following vaccination compared with immunocompetent individuals.

Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.

Although each of the product samples of phenibut contained the actual active ingredient, the exact amount of the active ingredient was inaccurate and, in one sample, found to be at a higher dose.

Pharmacists can educate patients on controlling risk factors and stay up-to-date on emerging therapies like SGLT2 inhibitors and finerenone that can slow disease progression.

Lp(a) is a critical risk factor for atherosclerotic cardiovascular disease, but current lipid-lowering therapies are largely ineffective at lowering Lp(a) levels.

Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.

Some outsourcers and pharmacies have capitalized on the shortages, producing compounded versions.

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

Adding HIV/AIDS to core chronic diseases is a key change.

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Plaintiff argues that "blacklisting” certain individuals with opioid prescriptions was unlawful.

Pharmacists are crucial in educating patients, identifying eligible individuals, and promoting uptake of the newly expanded RSV vaccination recommendations for older adults.

Study results show that the updated BNT162b2 XBB vaccine is effective in preventing hospitalizations or emergency department visits associated with COVID-19 complications.

Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Federal legislation would seek to foster development of antibiotics.

High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.

Adoption barriers include insurance coverage, patient and provider education, and regulatory hurdles that require aligned initiatives across stakeholders.

Proper reporting of errors and near misses helps maintain compliance and improve patient safety.

Researchers recommend early vaccination against herpes zoster to mitigate the risks.